Dasatinib inhibits c-src phosphorylation and prevents the proliferation of Triple-Negative Breast Cancer (TNBC) cells which overexpress Syndecan-Binding Protein (SDCBP).
Triple negative breast cancer (TNBC) progresses rapidly but lacks effective targeted therapies. Our previous study showed that downregulating syndecan-binding protein (SDCBP) in TNBC inhibits the proliferation of TNBC cells. Dasatinib is a new small-molecule inhibitor of c-src phosphorylation. The a...
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2017-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0171169&type=printable |
| _version_ | 1826579339456544768 |
|---|---|
| author | Xiao-Long Qian Jun Zhang Pei-Ze Li Rong-Gang Lang Wei-Dong Li Hui Sun Fang-Fang Liu Xiao-Jing Guo Feng Gu Li Fu |
| author_facet | Xiao-Long Qian Jun Zhang Pei-Ze Li Rong-Gang Lang Wei-Dong Li Hui Sun Fang-Fang Liu Xiao-Jing Guo Feng Gu Li Fu |
| author_sort | Xiao-Long Qian |
| collection | DOAJ |
| description | Triple negative breast cancer (TNBC) progresses rapidly but lacks effective targeted therapies. Our previous study showed that downregulating syndecan-binding protein (SDCBP) in TNBC inhibits the proliferation of TNBC cells. Dasatinib is a new small-molecule inhibitor of c-src phosphorylation. The aim of this study was to investigate if SDCBP is a potential marker to indicate whether a TNBC is suitable for dasatinib therapy. This study applied co-immunoprecipitation to identify the interaction between SDCBP and c-src in TNBC cell lines. In addition, immunohistochemistry was used to investigate SDCBP and tyrosine-419 phosphorylated c-src (p-c-src-Y419) expression in TNBC tissues. SDCBP-overexpressing MDA-MB-231 cells were then constructed to evaluate the effects of dasatinib on SDCBP-induced TNBC progression in vitro and tumor formation in nude mice. We found wild-type SDCBP interacted with c-src and promoted the phosphorylation of c-src; this phosphorylation was completely blocked by dasatinib. SDCBP lacking the PDZ domain had no such effect. Among the 52 consecutive random TNBC cases examined, the expression of SDCBP was consistent with that of p-c-src-Y419, and positively correlated with histological grading or Ki-67 levels. SDCBP overexpression significantly accelerated the proliferation and cell cycle progression of the TNBC cell line MDA-MB-231; these effects were prevented by dasatinib treatment. However, the subsequent inhibition of p27 expression partially restored the proliferation and viability of the TNBC cells. The results of this study suggest that SDCBP interacts with c-src, regulates G1/S in TNBC cells, and enhances tumor cell proliferation by promoting the tyrosine phosphorylation of c-src at residue 419. Dasatinib inhibits such phosphorylation and blocks SDCBP-induced cell cycle progression. Therefore, SDCBP might be an important marker for identifying TNBC cases that are suitable for dasatinib therapy. |
| first_indexed | 2024-12-21T18:42:26Z |
| format | Article |
| id | doaj.art-dd063ed71dad4327850d69854883ce92 |
| institution | Directory Open Access Journal |
| issn | 1932-6203 |
| language | English |
| last_indexed | 2025-03-14T14:16:42Z |
| publishDate | 2017-01-01 |
| publisher | Public Library of Science (PLoS) |
| record_format | Article |
| series | PLoS ONE |
| spelling | doaj.art-dd063ed71dad4327850d69854883ce922025-02-27T05:33:55ZengPublic Library of Science (PLoS)PLoS ONE1932-62032017-01-01121e017116910.1371/journal.pone.0171169Dasatinib inhibits c-src phosphorylation and prevents the proliferation of Triple-Negative Breast Cancer (TNBC) cells which overexpress Syndecan-Binding Protein (SDCBP).Xiao-Long QianJun ZhangPei-Ze LiRong-Gang LangWei-Dong LiHui SunFang-Fang LiuXiao-Jing GuoFeng GuLi FuTriple negative breast cancer (TNBC) progresses rapidly but lacks effective targeted therapies. Our previous study showed that downregulating syndecan-binding protein (SDCBP) in TNBC inhibits the proliferation of TNBC cells. Dasatinib is a new small-molecule inhibitor of c-src phosphorylation. The aim of this study was to investigate if SDCBP is a potential marker to indicate whether a TNBC is suitable for dasatinib therapy. This study applied co-immunoprecipitation to identify the interaction between SDCBP and c-src in TNBC cell lines. In addition, immunohistochemistry was used to investigate SDCBP and tyrosine-419 phosphorylated c-src (p-c-src-Y419) expression in TNBC tissues. SDCBP-overexpressing MDA-MB-231 cells were then constructed to evaluate the effects of dasatinib on SDCBP-induced TNBC progression in vitro and tumor formation in nude mice. We found wild-type SDCBP interacted with c-src and promoted the phosphorylation of c-src; this phosphorylation was completely blocked by dasatinib. SDCBP lacking the PDZ domain had no such effect. Among the 52 consecutive random TNBC cases examined, the expression of SDCBP was consistent with that of p-c-src-Y419, and positively correlated with histological grading or Ki-67 levels. SDCBP overexpression significantly accelerated the proliferation and cell cycle progression of the TNBC cell line MDA-MB-231; these effects were prevented by dasatinib treatment. However, the subsequent inhibition of p27 expression partially restored the proliferation and viability of the TNBC cells. The results of this study suggest that SDCBP interacts with c-src, regulates G1/S in TNBC cells, and enhances tumor cell proliferation by promoting the tyrosine phosphorylation of c-src at residue 419. Dasatinib inhibits such phosphorylation and blocks SDCBP-induced cell cycle progression. Therefore, SDCBP might be an important marker for identifying TNBC cases that are suitable for dasatinib therapy.https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0171169&type=printable |
| spellingShingle | Xiao-Long Qian Jun Zhang Pei-Ze Li Rong-Gang Lang Wei-Dong Li Hui Sun Fang-Fang Liu Xiao-Jing Guo Feng Gu Li Fu Dasatinib inhibits c-src phosphorylation and prevents the proliferation of Triple-Negative Breast Cancer (TNBC) cells which overexpress Syndecan-Binding Protein (SDCBP). PLoS ONE |
| title | Dasatinib inhibits c-src phosphorylation and prevents the proliferation of Triple-Negative Breast Cancer (TNBC) cells which overexpress Syndecan-Binding Protein (SDCBP). |
| title_full | Dasatinib inhibits c-src phosphorylation and prevents the proliferation of Triple-Negative Breast Cancer (TNBC) cells which overexpress Syndecan-Binding Protein (SDCBP). |
| title_fullStr | Dasatinib inhibits c-src phosphorylation and prevents the proliferation of Triple-Negative Breast Cancer (TNBC) cells which overexpress Syndecan-Binding Protein (SDCBP). |
| title_full_unstemmed | Dasatinib inhibits c-src phosphorylation and prevents the proliferation of Triple-Negative Breast Cancer (TNBC) cells which overexpress Syndecan-Binding Protein (SDCBP). |
| title_short | Dasatinib inhibits c-src phosphorylation and prevents the proliferation of Triple-Negative Breast Cancer (TNBC) cells which overexpress Syndecan-Binding Protein (SDCBP). |
| title_sort | dasatinib inhibits c src phosphorylation and prevents the proliferation of triple negative breast cancer tnbc cells which overexpress syndecan binding protein sdcbp |
| url | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0171169&type=printable |
| work_keys_str_mv | AT xiaolongqian dasatinibinhibitscsrcphosphorylationandpreventstheproliferationoftriplenegativebreastcancertnbccellswhichoverexpresssyndecanbindingproteinsdcbp AT junzhang dasatinibinhibitscsrcphosphorylationandpreventstheproliferationoftriplenegativebreastcancertnbccellswhichoverexpresssyndecanbindingproteinsdcbp AT peizeli dasatinibinhibitscsrcphosphorylationandpreventstheproliferationoftriplenegativebreastcancertnbccellswhichoverexpresssyndecanbindingproteinsdcbp AT rongganglang dasatinibinhibitscsrcphosphorylationandpreventstheproliferationoftriplenegativebreastcancertnbccellswhichoverexpresssyndecanbindingproteinsdcbp AT weidongli dasatinibinhibitscsrcphosphorylationandpreventstheproliferationoftriplenegativebreastcancertnbccellswhichoverexpresssyndecanbindingproteinsdcbp AT huisun dasatinibinhibitscsrcphosphorylationandpreventstheproliferationoftriplenegativebreastcancertnbccellswhichoverexpresssyndecanbindingproteinsdcbp AT fangfangliu dasatinibinhibitscsrcphosphorylationandpreventstheproliferationoftriplenegativebreastcancertnbccellswhichoverexpresssyndecanbindingproteinsdcbp AT xiaojingguo dasatinibinhibitscsrcphosphorylationandpreventstheproliferationoftriplenegativebreastcancertnbccellswhichoverexpresssyndecanbindingproteinsdcbp AT fenggu dasatinibinhibitscsrcphosphorylationandpreventstheproliferationoftriplenegativebreastcancertnbccellswhichoverexpresssyndecanbindingproteinsdcbp AT lifu dasatinibinhibitscsrcphosphorylationandpreventstheproliferationoftriplenegativebreastcancertnbccellswhichoverexpresssyndecanbindingproteinsdcbp |